Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jane H. Machacek"'
Autor:
Ann C. Cline, Bruce P. Ekholm, Inmaculada Soria, Jane H. Machacek, Paula Myhre, Lester I. Harrison, Anthony Pierce, Angela Helget, Zengri Wang
Publikováno v:
Clinical Drug Investigation. 22:523-531
Objective: To assess the bioequivalence of beclomethasone dipropionate (BDP) delivered from a press-and-breathe (PB) inhaler and a breath-actuated inhaler (Autohaler™, AH). Design: Two randomised, open-label, single-dose, four-period crossover stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::975e0f366c7e6f3b8d1a7e8c3b4806f3
https://doi.org/10.2165/00044011-200222080-00004
https://doi.org/10.2165/00044011-200222080-00004
Publikováno v:
Biopharmaceutics & Drug Disposition. 19:297-302
3M has formulated a new chlorofluorocarbon-free (CFC-free) beclomethasone dipropionate (BDP) metered-dose inhaler (MDI) with the use of the propellant HFA-134a (HFA). Lung deposition studies demonstrated that the HFA BDP MDI delivers to the lungs app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bb143bd275fa93de42dd94a4e86076b
https://doi.org/10.1002/(sici)1099-081x(199807)19:5<297::aid-bdd105>3.0.co
https://doi.org/10.1002/(sici)1099-081x(199807)19:5<297::aid-bdd105>3.0.co
Autor:
Janyce R. Nelson, Shaw F. Chang, Annette Purrington, Jane H. Machacek, Dianna R. Dahl, Ann C. Cline, Lester I. Harrison, Charlene Kannianinen
Publikováno v:
Biopharmaceutics & Drug Disposition. 18:635-643
As part of a development program to offer alternatives to chlorofluorocarbon (CFC) containing metered-dose inhalers, beclomethasone dipropionate has been formulated in a CFC-free system at three strengths: 50, 100, and 200 micrograms/actuation ex val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28c11492fbdcc6fa41c8a8e9271c37f4
https://doi.org/10.1002/(sici)1099-081x(199710)18:7<635::aid-bdd53>3.0.co
https://doi.org/10.1002/(sici)1099-081x(199710)18:7<635::aid-bdd53>3.0.co
Autor:
J. Adele Hoglin, Dianna J. Riedel, Lester I. Harrison, Tom S. Robison, Jane H. Machacek, Jeff M. Zumhofe, Jan K. Crowley, Charlene M. Kanniainen
Publikováno v:
American Journal of Therapeutics. 3:580-585
Plasma concentrations of nitroglycerin, 1,2-dinitroglycerin and 1,3-dinitroglycerin in 50 healthy male subjects who received single 24-h applications of two 0.6 mg/h drug-in-adhesive transdermal nitroglycerin patch formulations were compared for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3704c2c1ae98a5a58966b53fc15415b
https://doi.org/10.1097/00045391-199608000-00006
https://doi.org/10.1097/00045391-199608000-00006